Genomic Laboratory Hub Services

In October 2018, the National Test Directory (NTD) for Cancer was published.

The National Test Directory is updated each year to ensure access to the latest diagnostics and treatments. The NTD specifies which genomic tests are commissioned by the NHS in England, the clinical indication for which they apply and the technology by which the tests will be delivered.

Access to genomic services for HaemOnc patients will continue to be through your Specialist Integrated Haematological Malignancy Diagnostic Service (SIHMDS).

The NE&Y GLH cover three regional SIHMDS groups:

North East Haematological Oncology Diagnostic Service

Sheffield Haematological Oncology Diagnostic Service

Haematological Malignancy Diagnostic Service Leeds

Genomic haemato-oncology diagnostics are funded centrally by NHSE and so referring Trusts will not be charged for these services if they refer testing to their designated local GLH.

Note. Non-genetic activity carried out within an SIHMDS is funded separately and will still be charged for.

The Haemato-Oncology Team

Prof John Snowden
HaemOnc Lead Clinician
0114 2713357

Dr Catherine Cargo
HaemOnc Lead Clinician

Polly Talley
HaemOnc Lead Scientist


Gavin Cuthbert

Angharad Goodman


Rebecca Pollitt

Harveer Cheema


Paul Evans

Phil Dean

Genomic Multi-Disciplinary Team Meetings

In order to support the interpretation of genomic data and its integration within the clinical Multi-Disciplinary Team process a series of genomic advisory boards have been established.

These are multi-disciplinary teams who analyse the more complex genomic results which arise from testing for larger numbers of gene abnormalities.

GMT Meetings

National Genomic Test Directory

The 2020/2021 National Genomic Test Directory for rare and inherited disorders and cancer.

View Directory
Genomic Laboratory Hub Services